Insulet Corporation (PODD) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Devices secteur d'activité. Le siège social de l'entreprise est situé à Acton, MA, United States. Le PDG actuel est Ashley A. McEvoy.
PODD a date d'introduction en bourse 2007-05-15, 5,400 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $14.18B.
Insulet Corporation is a medical device company that develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's flagship product is the Omnipod System, a tubeless, self-adhesive disposable insulin pump worn on the body for up to three days, controlled wirelessly by a handheld personal diabetes manager. Insulet distributes its products through independent distributors, pharmacy channels, and direct sales across the United States, Canada, Europe, the Middle East, and Australia. Founded in 2000 and headquartered in Acton, Massachusetts, the company serves a global market of insulin-dependent diabetes patients seeking convenient, modern insulin delivery solutions.
